SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001136261-11-000083
Filing Date
2011-02-15
Accepted
2011-02-15 17:09:00
Documents
15
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1333087
3 COMPUTATION RATIO OF EARNINGS AVAILABLE TO COVER FIXED CHARGES exh12-1.htm EX-12.1 27495
4 SUBSIDIARIES exh21-1.htm EX-21.1 1037
5 CONSENT exh23-1.htm EX-23.1 1640
6 CEO 302 CETIFICATE exh31-1.htm EX-31.1 6616
7 CFO 302 CETIFICATE exh31-2.htm EX-31.2 6636
8 906 CETIFICATE exh32.htm EX-32 2902
9 10-K form10-k.pdf 10-K 1374124
10 COMPUTATION RATIO OF EARNINGS AVAILABLE TO COVER FIXED CHARGES exhibit12-1.pdf EX-12.1 7885
11 SUBSIDIARIES exhibit21-1.pdf EX-21.1 15380
12 CONSENT exhibit23-1.pdf EX-23.1 9719
13 CEO 302 CETIFICATE exhibit31-1.pdf EX-31.1 23843
14 CFO 302 CETIFICATE exhibit31-2.pdf EX-31.2 22018
15 906 CETIFICATE exhibit32.pdf EX-32 19313
16 LOGO logo.jpg GRAPHIC 7277
  Complete submission text file 0001136261-11-000083.txt   3420641
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23272 | Film No.: 11615031
SIC: 2836 Biological Products, (No Diagnostic Substances)